Oğuzhan Okcu

16PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersPlant and fungus systematics and taxonomyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Composite and hybrid materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 23, 2026
High TROP-2 expression as a predictor of poor neoadjuvant chemotherapy response in luminal B breast cancer: a retrospective clinicopathological study.

|Feb 11, 2026
A Life-Threatening Cause of Stridor, Primary Tracheal Actinomycosis.

Omer Topaloglu, Gokcen Sevilgen, Oguzhan Okcu

|Dec 30, 2025
Modulation of Oxidative and ER Stress Pathways by the ADAM17 Inhibitor GW280264X in LPS-Induced Acute Liver Injury.

Merve Huner Yigit, Oguzhan Okcu, Mehtap Atak

|Aug 14, 2025
Tumor budding and Ki-67 proliferation index as biomarkers for NAC response and prognosis in breast cancer.

Oğuzhan Okcu, Çiğdem Öztürk, Bayram Şen

|Aug 14, 2025
Impact of Tumor Budding in Head and Neck Cancers on Neck Lymph Node Metastasis and Prognosis.

Oğuz Gül, Özlem Çelebi Erdivanlı, Mehmet Birinci

|May 16, 2025
Perıostın and fıbronectın ın nasal lesıons: key players ın polyps and ınverted papıllomas.

Mehmet Birinci, Oğuzhan Okçu, Tuğba Yemiş

Pageof 3

Frequent Collaborators

10 joint publications

Çiğdem Öztürk

9 joint publications

Bayram Sen

4 joint publications

Mehmet Birinci

4 joint publications

Seda Duman Öztürk